title: Effective, selective and specific inhibition of COX-1 may overcome the "aspirin paradox".
authors.forename: Frederick A
authors.initials: FA
authors.lastname: Ofosu
mesh_terms: D000818:Animals; D001241:Aspirin / Q000627:therapeutic use*; D002341:Carotid Artery Thrombosis / Q000188:drug therapy*; D051545:Cyclooxygenase 1 / Q000378:metabolism*; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D014230:Triazoles / Q000627:therapeutic use*
chemical_list: C561773:3-methoxy-1,5-bis(4-methoxyphenyl)-1H-1,2,4-triazole; D016861:Cyclooxygenase Inhibitors; D005343:Fibrinolytic Agents; D014230:Triazoles; D051545:Cyclooxygenase 1; D001241:Aspirin